Prediction of mortality using dobutamine echocardiography

Pellikka, 1995, Stress echocardiography. Part II. Dobutamine stress echocardiography, Mayo Clinic Proc, 70, 16, 10.1016/S0025-6196(11)64660-0

Geleijnse, 1997, Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography, J Am Coll Cardiol, 30, 595, 10.1016/S0735-1097(97)00206-4

Picano, 1994, Detection of viable myocardium by dobutamine and dipyridamole stress echocardiography, Herz, 19, 204

Cornel, 1996, Assessment of myocardial viability by dobutamine stress echocardiography, Curr Opin Cardiol, 11, 621, 10.1097/00001573-199611000-00011

Poldermans, 1994, Dobutamine-atropine stress echocardiography for assessment of perioperative and late cardiac risk in patients undergoing major vascular surgery, Eur J Vasc Surg, 8, 286, 10.1016/S0950-821X(05)80143-4

Poldermans, 1995, Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography, J Am Coll Cardiol, 26, 648, 10.1016/0735-1097(95)00240-5

Marwick, 1997, Use of stress echocardiography for the prognostic assessment of patients with stable chronic coronary artery disease, Eur Heart J, 18, 97, 10.1093/eurheartj/18.suppl_D.97

Diamond, 1979, Analysis of probability as an aid in the clinical diagnosis of coronary artery disease, N Engl J Med, 300, 1350, 10.1056/NEJM197906143002402

Califf, 1996, Task force 5. Stratification of patients into high- medium- and low-risk subgroups for purposes of risk factor management, J Am Coll Cardiol, 27, 1007, 10.1016/0735-1097(96)87733-3

McNeill, 1992, Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography, Am J Cardiol, 70, 41, 10.1016/0002-9149(92)91387-J

Brown, 1998, Do stress echocardiography and myocardial perfusion imaging have the same ability to identify the low-risk patient with known or suspected coronary artery disease?, Am J Cardiol, 81, 1050

Mazeika, 1993, Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery disease, Am J Cardiol, 71, 33, 10.1016/0002-9149(93)90706-I

Afridi, 1994, Dobutamine stress echocardiography, Am Heart J, 127, 1510, 10.1016/0002-8703(94)90378-6

Poldermans, 1994, Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease, Am J Med, 97, 119, 10.1016/0002-9343(94)90021-3

Kamaran, 1995, Prognostic value of dobutamine stress echocardiography in patients referred because of suspected coronary artery disease, Am J Cardiol, 76, 887, 10.1016/S0002-9149(99)80255-0

Marcovitz, 1996, Value of dobutamine stress echocardiography in determining the prognosis of patients with known or suspected coronary artery disease, Am J Cardiol, 78, 404, 10.1016/S0002-9149(96)00327-X

Schroder, 1997, Comparison of the prognostic value of dipyridamole and dobutamine stress echocardiography in patients with known or suspected coronary artery disease, Am J Cardiol, 79, 1516, 10.1016/S0002-9149(97)00182-3

Steinberg, 1997, Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease, J Am Coll Cardiol, 29, 969, 10.1016/S0735-1097(97)00032-6

Pasquet A, Armstrong G, Rimmerman CR, Marwick TH. Myocardial Doppler velocity responses to exercise correlate with independent evidence of ischemia by dual isotope SPECT. Am J Cardiol. In Press.

Chuah, 1998, Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease, Circulation, 97, 1474, 10.1161/01.CIR.97.15.1474

Davar, 1999, Prognostic value of negative dobutamine stress echocardiography in women with intermediate probability of coronary artery disease, Am J Cardiol, 83, 100, 10.1016/S0002-9149(98)00788-7

Krivokapich, 1999, Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease, J Am Coll Cardiol, 33, 708, 10.1016/S0735-1097(98)00632-9

McCully, 1998, Outcome after normal exercise echocardiography and predictors of subsequent cardiac events, J Am Coll Cardiol, 31, 144, 10.1016/S0735-1097(97)00427-0

Kannel, 1972, Natural history of angina pectoris in the Framingham study. Prognosis and survival, Am J Cardiol, 29, 154, 10.1016/0002-9149(72)90624-8

Pryor, 1993, Value of the history and physical in identifying patients at increased risk for coronary artery disease, Ann Intern Med, 118, 81, 10.7326/0003-4819-118-2-199301150-00001

Shaw, 1999, The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients, J Am Coll Cardiol, 33, 661, 10.1016/S0735-1097(98)00606-8

Berman, 1990, Incremental value of prognostic testing in patients with known or suspected ischemic heart disease, J Am Coll Cardiol, 26, 639, 10.1016/0735-1097(95)00218-S

Hachamovitch, 1996, Exercise myocardial perfusion SPECT in patients without known coronary artery disease, Circulation, 93, 905, 10.1161/01.CIR.93.5.905

Machecourt, 1994, Prognostic value of thallium-201 single photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect, J Am Coll Cardiol, 23, 1096, 10.1016/0735-1097(94)90597-5

Oberman, 1989, Reproducibility of two-dimensional exercise echocardiography, J Am Coll Cardiol, 14, 923, 10.1016/0735-1097(89)90467-1

Hoffmann, 1996, Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms, J Am Coll Cardiol, 27, 330, 10.1016/0735-1097(95)00483-1

Marwick, 1999, The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) study group, Am J Med, 106, 172, 10.1016/S0002-9343(98)00388-X

Lauer, 1999, Cause of death in clinical research, J Am Coll Cardiol, 34, 618, 10.1016/S0735-1097(99)00250-8